Announcement

Collapse
No announcement yet.

Interesting info

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Interesting info

    COVID-19 Vaccine Talking Points from Weston A. Price Foundation - (citizens.org)

    By Citizens For Health COVID Corner December 28, 2020

    Please see below for an email alert from the Weston A. Price Foundation.

    Many of you have asked for information about the Covid-19 vaccines in order to educate your family and friends. We have compiled some key talking points below, and ask that you share them as widely as you can. If every recipient of this email could share it with ten others, and those recipients could share it with ten more, we could get this potentially life-saving information to millions of people!

    To print out these talking points in flyer format, visit https://www.westonaprice.org/wp-cont...kingPoints.pdf

    Thank you!

    The Weston A. Price Foundation

    COVID-19 VACCINES

    IMPORTANT TALKING POINTS

    Please Share with Your Family and Friends

    MINOR IMPACT: Vaccine manufacturers claim that Covid-19 vaccines are 95 percent “effective,” but the FDA is allowing companies to define effectiveness as “prevention of mild symptoms.” The studies are not designed to detect a reduction in outcomes such as severe illness, hospitalization or death.1,2 For individuals who develop severe symptoms, the vaccine is not a remedy. Instead, nutritional and oxidative support can help keep the illness from going into “overdrive.”3

    EXPECT ADVERSE REACTIONS: Participants in every Covid-19 vaccine trial have reported adverse reactions including high fever, chills, muscle pains and headaches.4-6 Some have even reported severe reactions that required hospitalization and invasive treatment. According to the FDA, potential long-term effects may include Guillain-Barré syndrome, brain swelling, muscle weakness and paralysis, convulsions and seizures, stroke, narcolepsy, shock, heart attack, autoimmune disease, arthritis and joint pain, multisystem inflammatory syndrome in children, and death.7 Some UK health workers have experienced anaphylactic shock after receiving one dose of the approved vaccine.8

    WON’T PREVENT COVID-19: An FDA Pfizer briefing paper published December 10, 2020 revealed 43 percent more suspected cases of Covid-19 in the vaccinated group than in the placebo group within seven days of vaccination.9

    NO LIABILITY: Covid-19 vaccine manufacturers will be protected from all liability—if you are injured, you cannot sue.10 Manufacturers will have complete indemnity even though all previous attempts at creating coronavirus vaccines caused harm and never advanced to regulatory approval.11

    WILL NOT END RESTRICTIVE MEASURES: Dr. Anthony Fauci of the National Institutes of Health acknowledges that the vaccines may prevent symptoms but will not block spread of the virus, so vaccine recipients will still need to wear masks, practice social distancing and avoid crowds.12,13

    NOT NECESSARY: According to the CDC’s current best estimate, the “infection fatality rate” (IFR) for Covid-19 is less than 1 percent for people age 69 and younger, including a .003 percent IFR for children and adolescents.14

    COULD MAKE YOU STERILE: Two prominent doctors, including the ex-head of Pfizer’s respiratory research, warn that Covid-19 vaccines contain a spike protein called syncytin-1, vital for the formation of the placenta.15 If the vaccine triggers an immune response to this protein, then female infertility, miscarriage or birth defects could result.

    FOR FURTHER INFORMATION: www.westonaprice.org/coronavirus/

    1. Doshi P. Will covid-19 vaccines save lives? Current trials aren’t designed to tell us. BMJ. 2020;371:m4037. https://www.bmj.com/content/371/bmj.m4037.

    2. Haseltine WA. Covid-19 vaccine protocols reveal that trials are designed to succeed. Forbes, September 23, 2020. https://www.forbes.com/sites/william...h=5da0663d5247.

    3. Brownstein D, Ng R, Rowen R et al. A novel approach to treating COVID-19 using nutritional and oxidative therapies. Science, Public Health Policy, and the Law. 2020;2:4-22. https://ozonewithoutborders.ngo/wp-c...o-Covid-19.pdf.

    4. Jackson LA, Anderson EJ, Rouphael NG et al. An mRNA vaccine against SARS-CoV-2 – preliminary report. New England Journal of Medicine. 2020;383(20):1920-1931. https://www.nejm.org/doi/full/10.1056/NEJMoa2022483.

    5. Allen A, Szabo L. NIH “very concerned” about serious side effect in coronavirus vaccine trial. Scientific American, September 15, 2020. https://www.scientificamerican.com/a...vaccine-trial/.

    6. Mayer A. Leading COVID vaccine candidates plagued by safety concerns. The Defender, November 13, 2020. https://childrenshealthdefense.org/d...?itm_term=home. .

    7. U.S. Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee, October 22, 2020 Meeting Presentation, slide #16. https://www.greenmedinfo.com/blog/co...ditions-possi1.

    8. Reals T. U.K. warns against giving Pfizer vaccine to people prone to severe allergic reactions. CBS News, December 9, 2020. https://www.cbsnews.com/amp/news/cov...reactions/#app.

    9. https://www.fda.giv/media/144245/download, page 42.

    10. Public Readiness and Emergency Preparedness Act. COVID-19 PREP Act Declarations. https://www.phe.gov/Preparedness/leg...s/default.aspx.

    11. Lyons-Weiler J. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. Journal of Translational Autoimmunity. 2020;3:100051. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142689/.

    12. Khemlani A. Fauci: Early COVID-19 vaccines will only prevent symptoms, not block the virus. Yahoo! Finance, October 26, 2020. https://finance.yahoo.com/news/fauci...195051568.html.

    13. Scipioni J. Dr. Fauci says masks, social distancing will still be needed after a Covid-19 vaccine—here’s why. CNBC, November 16, 2020. https://www.cnbc.com/2020/11/16/fauc...9-vaccine.html.

    14. Centers for Disease Control and Prevention. COVID-19 pandemic planning scenarios. Updated September 10, 2020. https://www.cdc.gov/coronavirus/2019...scenarios.html.

    15. Petition/motion for administrative/regulatory action regarding confirmation of efficacy end points and use of data in connection with the following clinical trials. Dr. Wolfgang Wodarg and Dr. Michael Yeadon, petitioners. Filed with European Medicines Agency, December 1, 2020. https://healthimpactnews.com/wp-cont...ial_FINAL_01DE C2020_EN_unsigned_with_Exhibits.pdf.
    Diplomacy is the art of saying 'Nice doggie' until you can find a rock.

    #2
    Sounds like poison
    Life Member: ASA, GOA, NRA

    Comment


      #3
      what could possibly go wrong ??????????????

      Comment


        #4
        Originally posted by Vitaman View Post
        ...According to the FDA, potential long-term effects may include Guillain-Barré syndrome...
        ...warn that Covid-19 vaccines contain a spike protein called syncytin-1, vital for the formation of the placenta ...
        These "talking points" are so packed full of misinformation that it isn't worth my time to respond to them all, but I'll pick the two that stand out the most to me at this time:

        First off, there have been ZERO recorded cases of Guillain-Barré syndrome from any of the vaccines circulating at the moment. Guillain-Barré syndrome is a tricky question. I recall shooting down a post on this board perhaps a year ago, with regards to it and the influenza vaccine. Suffice it to say that Guillain-Barré syndrome is a known consequence of a Covid19 infection, but is NOT believed to be associated with any of the vaccines. The FDA lists it as a potential side effect of ANY injection. Oh, and it's not a long-term effect. Guillain-Barré syndrome usually develops within 6 weeks of an infection.

        Second, last I recall, I don't have a uterus, so I'm really hoping I don't form a placenta.

        Comment


          #5
          it's fo da chillin

          Comment


            #6
            I heard Fauci said this as well. If it doesn't block the spread...... exactly WTF is it for?

            "WILL NOT END RESTRICTIVE MEASURES: Dr. Anthony Fauci of the National Institutes of Health acknowledges that the vaccines may prevent symptoms but will not block spread of the virus, so vaccine recipients will still need to wear masks, practice social distancing and avoid crowds.12,13"
            Exercise the Bill of Rights. It's good for your Constitution.

            Comment


              #7
              Originally posted by rlitman View Post

              These "talking points" are so packed full of misinformation that it isn't worth my time to respond to them all, but I'll pick the two that stand out the most to me at this time:

              First off, there have been ZERO recorded cases of Guillain-Barré syndrome from any of the vaccines circulating at the moment. Guillain-Barré syndrome is a tricky question. I recall shooting down a post on this board perhaps a year ago, with regards to it and the influenza vaccine. Suffice it to say that Guillain-Barré syndrome is a known consequence of a Covid19 infection, but is NOT believed to be associated with any of the vaccines. The FDA lists it as a potential side effect of ANY injection. Oh, and it's not a long-term effect. Guillain-Barré syndrome usually develops within 6 weeks of an infection.

              Second, last I recall, I don't have a uterus, so I'm really hoping I don't form a placenta.
              Guidance Barre- know someone that got it from eating undercooked chicken. It's no joke. Took almost a year recover and there's people that don't. Correct, not just the covid vaccine that can cause it, send a though any vaccine or any illness can set it off. Docs told the person I know to not get the flu shot since his recovery.
              The escape is nowhere near complete. The inventor of LIBERAL fishing. (soon to be seen on ESPN 45 because the 44th never worked.)

              Comment


                #8
                Originally posted by warmnfuzzy View Post
                it's fo da chillin
                Aren't children the least likely to get infected or die from the chicom flu?
                Exercise the Bill of Rights. It's good for your Constitution.

                Comment


                  #9
                  Originally posted by Vitaman View Post
                  COVID-19 Vaccine Talking Points from Weston A. Price Foundation - (citizens.org)

                  By Citizens For Health COVID Corner December 28, 2020

                  COULD MAKE YOU STERILE: Two prominent doctors, including the ex-head of Pfizer’s respiratory research, warn that Covid-19 vaccines contain a spike protein called syncytin-1, vital for the formation of the placenta.15 If the vaccine triggers an immune response to this protein, then female infertility, miscarriage or birth defects could result.

                  15. Petition/motion for administrative/regulatory action regarding confirmation of efficacy end points and use of data in connection with the following clinical trials. Dr. Wolfgang Wodarg and Dr. Michael Yeadon, petitioners. Filed with European Medicines Agency, December 1, 2020. https://healthimpactnews.com/wp-cont...ial_FINAL_01DE C2020_EN_unsigned_with_Exhibits.pdf.
                  This could make an interesting plot for a sci-fi movie...

                  Is the gateway to population control for Agenda 21?
                  WHAT IS AGENDA 21?

                  Agenda 21 – and the recent ones Agenda 2030 and Agenda 2050 – is a plan to depopulate 95% of the world population by 2030, according to Disclose.tv.. It is an action plan devised by the U.N. and signed by 178 governments at the UN Conference on Environment and Development held in Rio de Janeiro, Brazil, in 1992. Its goal is the depopulation of humanity because “we are too many”. It is promoted by the elites as a way to “save the planet” and implemented by governments worldwide. Bill Gates even shared his view about how to achieve this goal by vaccinations and other means in a TedX lecture: “The world today has 6.8 billion people. That’s heading up to about nine billion. Now if we do a really great job on new vaccines, health care & reproductive health services, we could lower that by perhaps 10 or 15 percent.” (HumansAreFree.com ).

                  Bill Gates, the Virus and the Quest to Vaccinate the World
                  https://www.nytimes.com/2020/11/23/world/bill-gates-vaccine-coronavirus.html
                  Published Nov. 23, 2020Updated Nov. 25, 2020

                  The billionaire is working with the W.H.O., drugmakers and nonprofits to defeat the coronavirus everywhere, including in the world’s poorest nations. Can they do it?

                  The head of one of the world’s largest vaccine manufacturers had a problem. Adar Poonawalla, chief executive of the Serum Institute of India, needed $850 million for everything from glass vials to stainless steel vats so he could begin producing doses of promising coronavirus vaccines for the world’s poor.

                  Mr. Poonawalla calculated that he could risk $300 million of his company’s money but would still be more than a half-billion dollars short. So he looked to a retired software executive in Seattle.

                  Bill Gates, the Microsoft founder turned philanthropist, had known Mr. Poonawalla for years. Mr. Gates had spent billions to help bring vaccines to the developing world, working closely with pharmaceutical executives to transform the market. In doing so, he became the most powerful — and provocative — private player in global health.

                  By the end of their conversation this summer, Mr. Gates had made a promise: The Bill and Melinda Gates Foundation would provide a $150 million guarantee so the Indian factory could move ahead with production. By September, the foundation had doubled its commitment.

                  Working behind the scenes is one of the world’s richest men, neither a scientist nor a doctor, who sees himself and his $50 billion foundation as uniquely prepared to take a central part. Mr. Gates and his team are drawing on connections and infrastructure the foundation has built over two decades to help guide the effort.

                  So far, it has pulled in only $3.6 billion in funding for research, manufacturing and subsidies for poor countries. AstraZeneca, one of three companies that have promised to deliver vaccines for the initiative, just announced impressive results. It is not yet known whether the other two will be effective. And it may be difficult to secure the necessary billions of doses in an affordable, timely way because the United States and other wealthy countries have cut separate deals for their citizens.

                  In recent months, Mr. Gates, who emphasizes that he is one of many involved in the vaccine effort, has hosted online round tables with drug company officials. He has pursuedfinancial commitments from world leaders: In one week alone, he and his wife and co-chair, Melinda Gates, spoke with President Emmanuel Macron of France, Chancellor Angela Merkel of Germany, President Ursula von der Leyen of the European Commission and Crown Prince Mohammed bin Zayed of Abu Dhabi.

                  In Washington, he has consulted frequently with Dr. Anthony S. Fauci, the nation’s chief infectious disease expert and a longtime collaborator on vaccine initiatives, and talked to Senator Mitch McConnell, a polio survivor who has been supportive of programsto eradicate that and other scourges. And to help staff the vaccine effort, his foundation has provided millions of dollars for McKinsey & Company consultants.

                  “Some people will say, ‘Why should it be him?’” said Dr. Ariel Pablos-Méndez, former director of knowledge management at the W.H.O. “He has the star power. He has the resources. He cares. There are many players that do things, but not at the scale of Gates.”

                  If the initiative, aided by Mr. Gates’s fortune and focus, manages to help protect the world’s poor from a virus that has already killed more than 1.3 million people, it will affirm the strategies he has promoted in his philanthropic work, including incentives for drug companies.

                  If the endeavor falls short, however, it could intensify calls for a more radical approach.

                  Amid the pandemic, some public health officials and advocates argue that vaccine makers, many of which have benefited from unprecedented public funding, should be compelled to share their technology, data and know-how to maximize production. India and South Africa, for example, are pushing to suspend the global enforcement of intellectual property rights involving the virus.

                  Dr. Zweli Lawrence Mkhize, South Africa’s health minister, said that the usual practices did not apply in this crisis. “There has to be a degree of broader consultation that looks at what is best for humanity,” he said in an interview.

                  In the current plan for a global vaccine deal, poor countries would receive only enough doses to inoculate 20 percent of their populations by the end of next year. Some models show that there will not be enough vaccines to cover the entire world until 2024.

                  “The consequence of longtime Gates strategies is that they go along with corporate control over supply,” said Brook Baker, a Northeastern University law professor and policy analyst for Health GAP, which advocates equitable access to drugs. “In a pandemic, that is a real problem.”

                  Meanwhile, officials from some countries participating in the vaccine initiative complain that they were barely consulted until recently. “They are pushing us, cornering us, in order to make us pay,” Juan Carlos Zevallos, Ecuador’s health minister, said of the dealmakers. “We don’t have a choice about which vaccine we would like to use. It is whatever they impose on us.”

                  As Mr. Gates has made public appearances to win support for the initiative, he has increasingly become the target of conspiracy theories that could undermine vaccination efforts.

                  Some falsely claim that his foundation tested vaccines that killed thousands of children in Africa and India, while others link him to bogus depopulation efforts. One poll from May found 44 percent of Republicans believed that the global immunization effort was a cover for Mr. Gates to implant microchips to track people. That claim is baseless.

                  Mr. Gates remains undaunted. “I’ve never heard either Bill or Melinda say anything to the effect of ‘We’ll just work on something else, this is too tough,’” said the billionaire investor Warren Buffett, who entrusted the Gates Foundation with $31 billion of his own fortune to give away. “The job is to work on tough problems.”

                  ‘The Bill Chill’


                  As a novel coronavirus linked to a live animal market began spreading rapidly in Wuhan, China, Mr. Gates watched from his office outside Seattle.

                  On Feb. 14, he and leaders at his foundation, fearing a global threat, gathered to plan a response. From that point on, Mr. Gates recalled, “we’re on Code Red.”

                  Two weeks later, Dr. Seth Berkley — chief executive of Gavi, the Vaccine Alliance, a nonprofit the Gates philanthropy helped found — flew to Seattle. Over breakfast, he and Mr. Gates considered how to get Covid-19 vaccines to the developing world. On March 13, two days after the W.H.O. declared a global pandemic, Mr. Gates conferred online with 12 top pharmaceutical executives, including the heads of Pfizer and Johnson & Johnson, which both have leading vaccine candidates.

                  He felt prepared for this moment, having built up global institutions and given away $55 billion to date, four times the influential Ford Foundation’s endowment.

                  Mr. Gates became interested in immunizations in the late 1990s, when Microsoft was facing an antitrust case that cast him as a modern-day robber baron. Vaccines involved creating new technology, his specialty. Their impact was measurable — inexpensive doses could protect hundreds of millions against devastating disease. They were also about making deals.

                  Many Western drug companies had stopped producing vaccines back then, finding them unprofitable. But through his giving, Mr. Gates helped create a new business model involving subsidies, advance market commitments and volume guarantees. The incentives drew in more manufacturers, including ones from the developing world, resulting in many more lifesaving vaccinations.

                  He brought a “technocratic expertise and power rather than a discourse of human rights and activism,” said Manjari Mahajan, an associate professor of international affairs at the New School who has written about Mr. Gates’s role in public health.

                  His foundation has spent more than $16 billion on vaccine programs, a quarter of that going to Gavi, and given $2.25 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Both organizations are based in Geneva, where the W.H.O. has its headquarters.

                  With a $100 million initial pledge, Mr. Gates helped create the Coalition for Epidemic Preparedness Innovations, in Oslo, to invest in drugs and experimental vaccines. (The coalition and Gavi are leadingthe coronavirus vaccine effort with the W.H.O.)

                  The foundation, which has about 1,600 employees, also funded academic researchers, installed its executives on the boards of multiple nonprofits and directly invested in drug companies.

                  One of them was the German company BioNTech, which got a $55 million equity investment in September 2019. The business, partnering with Pfizer, announced last week that their jointly developed Covid-19 vaccine appeared to be 95 percent effective, and applied to the Food and Drug Administration for emergency authorization.
                  Investments by the Gates Foundation in Covid-19 Vaccines
                  UMBRELLA ORGANIZATIONS

                  Gavi, the Vaccine Alliance $156 mil and again $300 mil.

                  Money set aside to buy vaccines in low-income countries through the global Covax program.

                  An advance commitment for the Serum Institute of India to produce 200 million doses for low- and middle-income countries. Coalition for Epidemic Preparedness

                  Innovations $20 mil.

                  Funding for a second wave of vaccines suited to conditions in the developing world.

                  INDIVIDUAL COMPANIES

                  SK Bioscience $3.6 mil.

                  Novavax Biological $15 mil.

                  E. Limited $4 mil.

                  Icosavax $10 mil.

                  Sources: Bill & Melinda Gates Foundation, New York Times research

                  Some public health officials disagreed with Mr. Gates’s priorities, arguing that he should have directed more money to health systems. Others worried about a private individual wielding so much influence. But few people publicly criticized his foundation, fearful of losing its support. That self-censorship was so widespread it acquired a nickname: “the Bill Chill.”

                  Some at the W.H.O. had concerns about his growing reach. The malaria division chief complained in a 2007 memo that the foundation’s growing dominance of malaria research was stifling a diversity of viewpoints among scientists and undercutting the agency. The same year, the foundation began building up an institute that rivaled the W.H.O.’s role in health metrics.

                  “The Gates Foundation presence has been, at best, an adjunct to W.H.O. and at worst a hostile takeover and a usurpation,” said Amir Attaran, a University of Ottawa professor of law and medicine.

                  Today, the foundation and the W.H.O. stress their mutual respect for each other. Publicly, Mr. Gates has made a point of praising the agency. “I can’t think of anything that we disagree with them,” he said in the interview.

                  Officials from the agency — which receives hundreds of millions of dollars annually from the foundation, its second-largest donor — said Mr. Gates had helped it become more efficient. “Gates pushes the science, pushes for the answers, because that’s a little bit of that private-sector mentality,” said Dr. Bruce Aylward, senior adviser to the W.H.O.’s director general.

                  As the coronavirus vaccine effort got underway, it was folded into a broader mission, coordinated by the W.H.O., to also provide Covid-19 diagnostic tests and therapies to the developing world. The agency wanted to take more of a leadership role in the vaccine deal making, but the Gates Foundation and global nonprofits said they worried that drugmakers would not cooperate. They worked to focus the agency’s role on regulating products and advising countries on distributing them, among other responsibilities.

                  “We’re always talking with W.H.O.,” Mr. Gates said. “But a lot of the work here to stop this epidemic has to do with innovation in diagnostics, therapeutics and vaccines, which isn’t really their bailiwick.”

                  Farah Dakhlallah, a W.H.O. spokeswoman, said that the organization had an “unmatched” ability to coordinate a global health response, and that the initiative leveraged “the comparative advantages” of its partners in the fight against Covid-19.

                  Capitalism at Work

                  In March, Mr. Gates was urging drugmakers to move fast, cooperate with one another, open up their libraries of drug compounds and even share production responsibilities.

                  “The first set of meetings, it was: ‘How are we going to find an active drug? How are we going to kick off vaccine development quickly? How are we going to shift manufacturing capacity?’” recalled Vasant Narasimhan, the chief executive of Novartis.

                  The Gates Foundation employs former pharmaceutical executives in its top ranks, including Dr. Trevor Mundel, who had been global head of development at Novartis, and Emilio Emini, previously a senior vice president of vaccine research at Pfizer. Working with the Coalition for Epidemic Preparedness Innovations, they helped steer money into Covid-19 vaccine candidates and biotechnologies that could be quickly manufactured and suitable for the developing world.

                  Oxford University said it would offer “nonexclusive, royalty-free licenses” of its work to manufacturers. But as it developed one of the most promising vaccine candidates, the university debated whether it was equipped to conduct clinical trials and transfer its technology to manufacturers around the world.

                  Sir John Bell, who leads the development of Oxford’s health research strategies and chairs the Gates Foundation’s scientific advisory committee, reached out to Dr. Mundel. The advice was direct: “We told Oxford, ‘Hey, you’ve got to find a partner who knows how to run trials,’” Mr. Gates said.

                  Oxford chose the British-Swedish drugmaker AstraZeneca. The Serum Institute of India, after getting the financial commitment from Mr. Gates, agreed in the summer to start producing the vaccine.

                  All the while, the United States and other countries were striking their own deals with vaccine makers, even before they got regulatory approval. There was some overlap between the global initiative and the American effort, called Operation Warp Speed. AstraZeneca, Novavax and Sanofi made commitments to both.

                  Mr. Gates was quick to praise the U.S. government’s enormous investment in expediting coronavirus vaccines, saying it would benefit everyone. But the more that countries locked down bilateral deals, the longer the rest of the world would have to wait for doses.

                  Mr. Gates had valuable insights from Dr. Fauci, who leads the National Institute of Allergy and Infectious Diseases. More than a decade ago, the billionaire had invited Dr. Fauci to his home to join a discussion about tuberculosis. Since then, they have coordinated efforts aimed at fighting not just that disease but also malaria, polio and AIDS.

                  The two men spoke every few weeks. Dr. Fauci wanted to know how vaccine trials in foreign countries were playing out. Mr. Gates was interested in how the U.S. regulatory process was going and whether vaccines the American government was purchasing would be suited for poor countries. The Pfizer and BioNTech vaccine, for instance, requires two doses and ultracold storage, obstacles in many places.

                  “He wanted to make sure, which is the classic Bill Gates, that as we do the vaccines, that it’s the kind of vaccine that could be used in the developing world,” Dr. Fauci said in an interview.

                  During the pandemic, Latin America has suffered a third of the world’s deaths. Africa has now passed two million cases. Quarantines and trade shutdowns have hit poor countries especially hard, where not working often means not eating.

                  Some public health advocates and on-the-ground providers like Doctors Without Borders thought Mr. Gates was doing too little to pursue equitable access to vaccines and was too aligned with the pharmaceutical industry.

                  “Part of what they like about him is he’s protecting their way of life,” James Love, director of Knowledge Ecology International, a nonprofit that works to expand access to medical technology, said of Mr. Gates and drug industry executives. “Because this message is always, ‘Big Pharma is awesome.’”

                  He and others believed that vaccine makers would not maximize production for the developing world, especially when rich countries were clamoring for doses, because it wouldn’t serve their bottom line. India and South Africa, in asking the World Trade Organization not to enforce coronavirus-related intellectual property rights, were seeking a way to wrest control of vaccines from big companies and ramp up local manufacturing. Kenya, Mozambique, Pakistan and Eswatini (formerly Swaziland) recently signed on as co-sponsors to the request, with dozens of other countries expressing support.

                  But Mr. Gates and many public health experts thought that most companies were taking laudable steps to help ensure access, such as nonprofit pricing and licensing of their technology to other manufacturers. They argued that drugmakers wouldn’t take on the costly process of creating new products if their lucrative patents were jeopardized and that their control over their vaccines would ensure quality and safety.

                  “This capitalism thing — there actually are some domains that actually works in,” Mr. Gates said. “North Korea doesn’t have that many vaccines, as far as we can tell.”

                  ‘Acting Like a Lobbyist’

                  It was May 4, and Mr. and Mrs. Gates were on a video call with Boris Johnson. They congratulated the British prime minister on the birth of his son, and asked about the Covid-19 case that had sent him to the hospital.

                  Then they made their pitch: The world would never be safe from the virus, and the global economy would never recover, unless poor countries received vaccines and treatments, too.

                  Mr. Gates had a long record of getting rich countries to provide funding for public health initiatives in poorer countries. From Ms. Merkel to Mr. McConnell, politicians saw him as a steward of public dollars with a nose for good investments.

                  “He has immediate access to us because of his fame and reputation and what he’s doing with his own money,” Mr. McConnell, the Senate majority leader, said in an interview. “In many of these countries, he’s way more effective than the government is, and that’s certainly value added for public health all over the world.”

                  Significant donations came from Britain, the European Union and elsewhere. China pledged its cooperation last month. But Mr. Gates made no headway with his home country.

                  He had asked the Trump administration and Congress for $8 billion, half for the global vaccine effort and half for therapeutics and diagnostics in poor countries. In private calls, Mr. Gates, who had forged ties with leaders of both parties but remained nonpartisan over the years, made his case to Vice President Mike Pence, House Speaker Nancy Pelosi and others.

                  He put himself in the public eye more than ever before, often appearing in a pastel sweater that drew comparisons to Mister Rogers, and repeating in interviews that the pandemic required an international response. “He’s made a choice to become very public, very political, where he’s acting like a lobbyist,” said Lawrence Gostin, professor of global health law at Georgetown.

                  But Mr. Trump had no intention of joining a global response. That became clear in July, when he withdrew the United States from the W.H.O., which it had provided with more than $400 million in annual contributions.

                  “People aren’t used to not having the U.S. step forward,” Mr. Gates said. On the global vaccine effort, he acknowledged, the nation has been “a no-show.” President-elect Joseph R. Biden Jr. may well take a different position, having vowed to rejoin the W.H.O.

                  Leaders of wealthy countries were asked not only to help fund the initiative — which was supporting development of nine potential vaccines— but also to buy doses for their own populations. Among the nine was a version from Moderna, which recently announced impressive clinical trial results. As the deal makers framed it, even nations that already had commitments from vaccine makers would benefit by diversifying.

                  Companies either would charge all countries the same price or set tiered prices for low-, middle- and high-income nations; any could bow out if the price exceeded $21 per dose.Poor countries could get cheap, subsidized doses for up to 20 percent of their populations by the end of next year, but the wealthier nations could sign up for more.

                  Clemens Martin Auer, a chief negotiator for the European Union, balked, believing that the global vaccine deal was moving too slowly, that prices would be too high and that Europe could do better negotiating on its own.

                  “I think the Gates Foundation has in many respects a very practical approach when they say this has to be done in a private-public business partnership,” he said. “But I sometimes have my impression that the Gates Foundation doesn’t understand how well-organized governments work.”

                  With so much attention on wealthy nations, there was little consultation with those the effort was intended to help most. It wasn’t until the fall that lower-income countries learned they would have to pay $1.60 or $2 per dose, a significant price that would require some to secure bank loans or grants.

                  “It’s going to be subsidized, yes, but countries still have to budget for their co-pay amount,” said Chizoba Barbara Wonodi, the Nigeria directorat the Johns Hopkins International Vaccine Access Center. “So they need to be at the table when those discussions are made.”

                  Some middle-income countries have also felt squeezed, asked to pay prices in a higher tier with little say as to what they would get or when they would get it.

                  Mr. Zevallos, the Ecuadorean health minister, said he had spoken with fellow ministers in the region about raising concerns through their presidents. “They say, ‘You don’t get to choose, but you pay,’” Mr. Zevallos said. “I’m disappointed.”

                  Dr. Berkley, the Gavi director, acknowledged the frustration. “Did we communicate with everybody as well as we should? Absolutely not,” he said. “Were we able to convene everybody as often as we could? Absolutely not. But we did our best to try to do that.”

                  At the same time, Dr. Berkley said: “Have we brought together the entire world to discuss equitable access to vaccines? Have we raised substantial amounts of funds? All of that is true.”

                  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                  It's a long read, but it ties a lot of loose ends up.

                  Its source is the New York Times, the Flag Ship for Progressivism.

                  In the Corona Aid Package, there is a lot of Foreign Aid to 3rd World countries. No matter where it's earmarked, it could become Vaccine funding.

                  Bill had his hands in almost every part of the Vaccine production and distribution and has Population Control as an agenda.

                  McKinsey & Company consultants is a well-known Kingmaker. Some of their previous employees include Chelsea Clinton. Here's the list:
                  https://en.wikipedia.org/wiki/List_o...ey_%26_Company

                  There are many more examples of interesting coincidences but I'll leave it up to you and your imagination to add to this Movie Plot.








                  True freedom and our inherent responsibility:
                  https://www.biblegateway.com/passage...18&version=NLT
                  https://www.biblegateway.com/passage...hronicles+7:14

                  Comment


                    #10
                    Originally posted by Barnslayer View Post
                    I heard Fauci said this as well. If it doesn't block the spread...... exactly WTF is it for?

                    "WILL NOT END RESTRICTIVE MEASURES: Dr. Anthony Fauci of the National Institutes of Health acknowledges that the vaccines may prevent symptoms but will not block spread of the virus, so vaccine recipients will still need to wear masks, practice social distancing and avoid crowds.12,13"
                    It's for Fauci's retirement.
                    Giza Development: Building and Renovating Pyramids of Distinction Since 2435 BC 631-427-1691 (Beware the Sea People)

                    Comment

                    Working...
                    X